drugset / Trial / NCT03367962

Detection of Graft Versus Host Disease With [18F]F-AraG

NCT03367962 ↗

Non-randomizedParallel-groupOpen-labelDiagnostic

Summary

This is a single-center imaging study to determine utility of in vivo imaging with \[18F\]F-AraG to identify sites of Graft Versus Host Disease (GVHD) in patients highly suspected of having acute GVHD who require systemic therapy, and patients at high risk for developing acute GVHD. \[18F\]F-AraG PET scans will be compared to biopsy results to correlate T cell accumulation which is implicated in the disease. High risk patients will be followed to verify predictive potential of \[18F\]F-AraG.

Timeline

Start
2018-05-15
Primary completion
2023-06-21
Completion
2023-10-21

Drugs

EvaluationDrugModalityDoseRoute
Subject F-ARAG Diagnostic / imaging agent 5 mbq Intravenous